HPX and Hepatic fibrosis: In this study, we developed a mLC-MS/MS-PRM assay for the quantification of site-specific mucin-type O-glycoforms of hemopexin, which we previously reported as a promising candidate biomarker for the serologic monitoring of liver fibrosis [11,12].